Clin Endosc.  2021 Jan;54(1):32-37. 10.5946/ce.2019.198.

Trends of Colorectal Cancer Prevalence in Kazakhstan Related to Screening

Affiliations
  • 1Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
  • 2National Research Oncology Center, Nur-Sultan, Kazakhstan
  • 3Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan

Abstract

We carried out an analysis of the total incidence of colon cancer throughout Kazakhstan. Retrospectively, according to the regional reports on endoscopic screening, the study showed an increase in the age-related incidence of colorectal cancer (CRC) cases from 2004–2008 to 2009–2014. The peak of morbidity in both periods was noted in the age category of >70 years. The indicators of the territorial distribution of CRC incidence make it possible to divide the regions into areas with low or high rates of CRC. Specific indicators showed newly diagnosed cases of CRC stages I, II, III, and IV in 2004–2018. The incidence rates of stages I and II showed a two-fold increase (35%–67.4%) and the incidence of stage IV showed a decline from 19.3% to 13.1% and of stage III from 45.7% to 19.5% from 2004 to 2018, respectively. An analysis of CRC incidence throughout Kazakhstan showed an increase in the overall incidence. Since population-based CRC screening was introduced in 2011, the morbidity was found to increase for stages I and II.

Keyword

Colonoscopy; Colorectal cancer; Hemoccult test; Kazakhstan; Screening

Figure

  • Fig. 1. The incidence and mortality of colorectal cancer in Organization for Economic Cooperation and Development countries and Kazakhstan.

  • Fig. 2. Dynamics of World Health Organization world standardized indicators of incidence and mortality from colorectal cancer per 100,000 population of Kazakhstan for the period 2004–2018.

  • Fig. 3. Age indicators of the incidence of colorectal cancer in Kazakhstan (average per 100,000 inhabitants of the corresponding age for 2004–2011 and 2012–2018).

  • Fig. 4. Proportion of I-II, III, IV stages of primary cases of colorectal cancer in Kazakhstan (%).

  • Fig. 5. Territorial incidence rates of colorectal cancer in Kazakhstan (standardized World Health Organization world rates per 100,000 population, 2004–2010, 2011–2014 and 2015–2018).


Reference

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.
Article
2. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019; 144:1941–1953.
Article
3. Abdullayev MS, Nurgaziev KS, Zhylkaydarova AZ, Mansurova AB. Epidemiological aspects of colorectal cancer in Kazakhstan. Surgery News. 2017; 25:394–403.
Article
4. Batyrbekov KU. [Some aspects of endoscopic colorectal cancer screening in Kazakhstan]. Avicenna Bulletin. 2016; 3:38–41.
5. Kaidarova DR, Zhylkaidarova AZH, Akhetov AA, Shanazarov NA, Batyrbekov KU. [Change of epidemiological situation of colorectal cancer in Kazakhstan after introduction of screening]. Avicenna Bulletin. 2018; 2-3:157–165.
6. Order of the minister of health of the Republic of Kazakhstan dated December № 995 "On approval of the rules of preventive medical examinations of the target population" [Internet]. Almaty: Ministry of Justice of the Republic of Kazakhstan;c2017. [updated 2017 Dec 25; cited 2019 Aug 24]. Available from: http://adilet.zan.kz/rus/docs/V1700016223#z6.
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr